Akèy › Distrofi myotonik › New York › Rochester
Etid klinik pou Distrofi myotonik nan Rochester, NY
7 etid pou Distrofi myotonik ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Ap rekriteFaz 3
- University of Rochester Medical Center, Rochester
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Ap rekriteEtid obsèvasyon
- University of Rochester Medical Center, Rochester
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Ap rekriteEtid obsèvasyon
- University of Rochester, Rochester
Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
Ap rekriteEtid obsèvasyon
- University of Rochester, Rochester
Remote Assessments and Genetic Determinants of Myotonic Dystrophy
Ap rekriteEtid obsèvasyon
- University of Rochester, Rochester
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Rochester Medical Center, Department of Neurology, Rochester
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
Ap rekriteFaz 2/3
- University of Rochester - Medical Center, Rochester
Etid Distrofi myotonik nan lòt vil
Lòt etid nan Rochester
- Leksemi mieloïd egi16 etid
- Kansè poumon15 etid
- Kansè nan tete15 etid
- Kansè (tout kalite)14 etid
- Obèsite14 etid
- Kansè Poumon ki pa ti selil13 etid
- Sipwa13 etid
- Kansè pwostat10 etid
- Myelom Miltip8 etid
- Kansè Metastatik8 etid
- Kansè pankreyas7 etid
- Kansè vejik7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.